European Generic Markets: Regulatory Approaches Across the EU
The EU's generic drug market is shaped by four approval pathways, each with different timelines and costs. The 2025 Pharma Package reforms are accelerating market entry, but national inconsistencies still delay access for patients across Europe.
Read More
